Nanotechnology Now - News Story: "Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?"

Home > News > Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?

September 13th, 2005

Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?

Abstract:
Nanotechnology is poised to enable advances that could be utilized to shave time and expense from multiple stages of the drug discovery and development efforts.

Source:
nano.cancer.gov

Bookmark:

Related Links

Ohio State University

National Cancer Institute

Related News Press

Possible Futures

Lifeboat publishes its first book: The Lifeboat Foundation has published its first book, "The Human Race to the Future: What Could Happen -- and What to Do" May 14th, 2013

UC Santa Barbara History Professor's Book Elucidates, Celebrates ‘Visioneers' May 14th, 2013

Conceptual Nanomedical Lipofuscin Removal Strategy April 29th, 2013

The Global Desalination Market 2013-2023 April 24th, 2013

Nanomedicine

UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013

Single-Cell Transfection Tool Enables Added Control for Biological Studies: McCormick researchers develop method of delivering molecules into targeted cells May 22nd, 2013

How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013

MU Researchers Develop Radioactive Nanoparticles that Target Cancer Cells: This is an early step toward developing therapies for metastasized cancers, MU scientist says May 21st, 2013